Richard Groenendijk

Managing Partner - CFO / IR

Richard Groenendijk is an experienced finance executive with a strong background in the biopharma and emerging markets sectors. As the Managing Partner - CFO / IR at Remora Biotech, he oversees the firm's financial operations, investor relations, and strategic initiatives. Additionally, he serves on the Board of Directors at MKB Biopharma, leveraging his expertise to guide the company's growth and development.

Professional Experience

Current Role

Managing Partner - CFO / IR, Remora Biotech (2018-Present)

Responsible for the overall financial management and strategic direction of the company

Leads the investor relations function, ensuring effective communication with shareholders and the investment community

Plays a key role in shaping the firm's growth strategy and exploring new business opportunities

Board Member, MKB Biopharma (2022-Present)

Provides strategic guidance and oversight to the company's leadership team

Contributes expertise in financial management, regulatory affairs, and international expansion

Career Progression

Senior Advisor Russia / Manager- Emerging Markets, CONTINENTAL CAPITAL MARKETS S.A. (2010-2016)

Spearheaded the firm's expansion into emerging markets, including Russia and the Balkans

Advised clients on investment strategies and navigating complex regulatory environments

Head of CIS/Balkans - Senior Partner, Kepler Cheuvreux (2002-2010)

Led the company's operations in the Commonwealth of Independent States (CIS) and Balkans regions

Grew the firm's client base and oversaw the execution of numerous cross-border transactions

Global Foreign Exchange – FX Sales & Trading, Rabobank (1997-2002)

Gained extensive experience in foreign exchange trading and client advisory services

Developed strong relationships with institutional clients and counterparties

Education

Master's Degree in Finance, Erasmus University Rotterdam

Bachelor's Degree in Economics, Erasmus University Rotterdam

Areas of Expertise

Financial management and strategic planning

Investor relations and capital markets advisory

Emerging markets investment and operations

Cross-border transactions and international expansion

Regulatory compliance and risk management

Professional Impact

Played a pivotal role in Remora Biotech's growth, strengthening its financial position and investor relations

Contributed to the strategic direction and governance of MKB Biopharma as a board member

Demonstrated a proven track record of navigating complex emerging markets and driving business expansion

Conclusion

With his comprehensive finance expertise, deep industry knowledge, and proven leadership abilities, Richard Groenendijk is well-positioned to continue delivering value to Remora Biotech, MKB Biopharma, and their respective stakeholders. His strategic vision and commitment to driving sustainable growth make him a valuable asset in the dynamic biopharma and investment management sectors.